New, simple, highly sensitive, precise, and accurate gradient reversed-phase chromatographic methods were developed using HPLC and ultra-HPLC (UPLC) systems for the determination of five components, namely thiamine, pyridoxine, cyanocobalamin, benfotiamine, and diclofenac in tablets and capsules. The methods were compared for their efficiency in the separation and determination of these five compounds using two different C18 columns (250 × 4.6 mm, 5 μm; and 100 × 4.6 mm, 2.6 μm) for HPLC and UPLC, respectively. Chromatographic separation was performed with a mobile phase containing acetonitrile and 0.025 M phosphate buffer (pH 3.5), with a gradient program and a flow rate of 1.5 and 1.0 mL/min for both methods, respectively. The methods were validated according to International Conference on Harmonization guidelines. Linearity was achieved in the range of 5.00 to 150.00 μg/mL for each of the five compounds. Ruggedness and intermediate precision were confirmed by different analysts on different columns on different days. Moreover, the components were subjected to an accelerated stability study under acidic, alkaline, and oxidative stress conditions and no interfering peaks were observed. The five compounds were efficiently separated in <20 min by HPLC, whereas for UPLC, separation was achieved in <8 min, which dramatically decreased the consumption of organic solvents.
S
ince the advent of chromatography as an analytical separation technique in the 1940s, substantial and continuous developments have led to the application, and thus maximization, of chromatography in different fields. The efficiency of chromatographic separation columns is measured by the number of theoretical plates (N), which is directly proportional to the column length (L) and inversely proportional to the particle diameter (dp). A reduction in dp will lead to high back-pressure, which consequently requires the introduction of the mobile phase under pressure (1) . Chromatographic system design has improved considerably over time, beginning with conventional columns (dp of 50-100 μm), then HPLC (dp of 5 μm), and lastly UPLC (dp ≤ 2 μm), which is the best use of the method. Columns were shortened and the mobile phase was introduced under pressure, which in HPLC does not exceed 400 bar, whereas in UPLC, for columns of ≥15 cm, pressure can reach 1200 bar. Developing stationary phases that can withstand these conditions has been a challenge. The recent introduction of UPLC as a new trend in LC retains the practicality and principles of HPLC, but leads to higher sensitivity and minimizes separation time and solvent consumption (2) . Today most QC laboratories have made the transition from HPLC to UPLC to save time and money.
Thus, the aim of our paper was to develop and compare the efficiency of HPLC and UPLC methods for the separation of a five-component mixture made from tablets and capsules. Both methods can be applied in laboratories, each according to the equipment available. The analyzed mixture was composed of vitamin B complex-thiamine (B1), pyridoxine (B6), cyanocobalamin (B12), and benfotiamine (BEN; vitamin B1 derivative)-as well as diclofenac (DIC). DIC is a nonsteroidal anti-inflammatory drug that is commonly coformulated with vitamin B complex to reduce inflammation (3) . The chemical structures of the five compounds can be seen in Figure 1 . Analysis of pharmaceutical formulations containing this mixture can be challenging due to the presence of vitamin B12 in very small amounts relative to the other components. In a previous work in our laboratory (4), a spectrophotometric-assisted chemometric method using a multivariate curve resolutionalternating least-squares algorithm was developed to analyze the mixture. However, considering most laboratories use LC techniques because of their greater selectivity and sensitivity as compared with spectrophotometric methods, we set out to address selectivity and sensitivity in our present work.
The compounds under study were previously analyzed either individually or in multicomponent mixtures. These methods include spectrophotometry (5, 6) , atomic absorption spectrometry (7), and capillary electrophoresis (8) (9) (10) . Several reported methods used HPLC for the determination vitamins B1, B6, and B12 in combination with other compounds or with fat-soluble vitamins (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . However, we did not find an HPLC method for the simultaneous determination of all five components in the literature. Our aim, therefore, was to develop and compare both HPLC and UPLC methods for the separation and determination of the five components in their pure forms and in tablets and capsules. 
Experimental

Instrumentation
Standard Solutions
Stock standard solutions.-Stock standard solutions (1 mg/mL) of B1, B6, B12, BEN, and DIC were prepared by separately dissolving accurately weighed standard equivalent to 100 mg of base for each compound in 100 mL methanol.
Working standard solutions.-Working standard solutions (100 μg/mL) of B1, B6, B12, BEN, and DIC were prepared by diluting 10 mL of each stock standard solution in 100 mL methanol.
Solutions for accelerated stability study.-Base hydrolysis.-An accurately weighed standard equivalent to 100 mg of each compound (equivalent to its base) was transferred into a 100 mL volumetric flask, dissolved in 20 mL of 0.1 N NaOH, and placed in a boiling water bath for 15 min. The solution was cooled, neutralized with 0.1 N HCl, and diluted to a 100 mL with methanol.
Acid hydrolysis.-An accurately weighed standard equivalent to 100 mg of each compound (equivalent to its base) was transferred into a 100 mL volumetric flask, dissolved in 20 mL of 0.1 N HCl, and placed in a boiling water bath for 15 min. The solution was cooled, neutralized with 0.1 N NaOH, and diluted to a 100 mL with methanol.
Oxidation by hydrogen peroxide.-An accurately weighed standard equivalent to 100 mg of each compound (equivalent to its base) was transferred into a 100 mL volumetric flask, dissolved in 20 mL of 30% H 2 O 2 , and placed in a boiling water bath for 15 min. The standard was cooled and diluted to a 100 mL volume with methanol.
Ten milliliters of each of the previously prepared solutions to be used for stability testing were then diluted to a 100 mL volume with methanol and then the specified chromatographic conditions applied.
Chromatographic Conditions
HPLC chromatographic separation was performed at ambient temperature using a Zorbax Eclipse Plus C18 column (250 × 4.6 mm, 5 μm; Agilent) as the stationary phase, with detection at 254 nm, a 10.0 μL injection volume, and a flow rate of 1.5 mL/min. Gradient elution was performed as follows: Solvent A was composed of acetonitrile. Solvent B was composed of 0.025 M potassium dihydrogen phosphate, pH 3.5 (adjusted with o-phosphoric acid), starting with 88% of B to achieve 40% of B at 12 min and maintained up to 20 min, whereas for UPLC, separation was performed at 40°C using a Kinetex C18 column (100 × 4.6 mm, 2.6 μm; Phenomenex, with detection at 254 nm, a 10 μL injection volume, and a flow rate of 1.0 mL/min. Gradient elution was performed as follows: Solvent A was composed of acetonitrile. Solvent B was composed of 0.025 M potassium dihydrogen phosphate, pH 3.5 (adjusted with o-phosphoric acid), starting with 100% of B for up to 1.8 min, then a gradual increase to 100% of A at 10 min. Before the first injection, the columns were preconditioned to the same operating temperatures for ~20 min. The prepared buffers were degassed in an ultrasonic bath for 15 min and then filtered using a vacuum pump.
Construction of Calibration Curves
A series of standard solutions for B1, B6, B12, BEN, and DIC were prepared by appropriate dilutions from each stock and working standard solution in 10 mL measuring flasks with methanol to prepare the solutions for a concentration range of 5.0 to 150.0 μg/mL. The solutions were chromatographed under the previously stated conditions. Each solution was injected in triplicate and the average integrated peak area plotted against its corresponding concentration. Linearity plots were constructed, and acceptable fit to linear regression was shown.
Analysis of Pharmaceutical Formulations
Ten Arthineur capsules were accurately weighed and neatly evacuated, and then the empty capsules were accurately weighed. Their powder content was calculated as the difference between the recorded weights. Ten Milga tablets were accurately weighed and finely powdered. Separate weights from the capsule content and the powdered tablets, each equivalent to one capsule or one tablet, respectively, were accurately weighed, transferred into a 50 mL measuring flask, diluted with methanol, ultrasonicated for ~10 min in triplicate, and then diluted to the volume with methanol and used to determine B12. Then, appropriate dilutions were performed to determine the four other compounds. The specified chromatographic conditions were applied to the prepared dosage form solutions using HPLC and UPLC methods.
Validation Procedure
Both HPLC and UPLC methods were validated for specificity, linearity, sensitivity, precision, and accuracy according to International Conference on Harmonization (ICH) guidelines (24) . The linearity of the peak area for each compound at different concentrations injected in triplicate was evaluated. Solutions were injected in triplicate into both HPLC and UPLC systems, then calibration graphs obtained as described above. Regression data analysis was performed using least-squares linear regression statistical analysis. The LOD and LOQ were calculated according to ICH using the SD of regression residuals. Precision studies were determined at three concentration levels for each compound (20.00, 80.00, and 140.00 μg/mL) and represented by RSD, %. Repeatability was assessed by preparing and injecting in triplicate solutions at the three concentrations on the same day, whereas intermediate precision was evaluated on three different days by different analysts on different columns. To verify the accuracy of the method, recovery experiments were performed after the addition of a known amount of pure drug to the preanalyzed tablets. All necessary system suitability test parameters were calculated for both methods. An accelerated degradation study was performed to determine any stability-indicating properties and the specificity of the HPLC method. Accelerated degradation was attempted using acid, base, and oxidative conditions (25) .
Results and Discussion
In this work, the efficiency of reversed-phase gradient HPLC and UPLC methods was compared for the determination of a five-component mixture of vitamins B1, B6, B12, and BEN and DIC in their pharmaceutical preparations.
Method Development and Optimization of Chromatographic Conditions
The most important parameter in LC method development is sufficient resolution to distinguish the target compound from other compounds and any other excipients, interferences, and matrix effects from the sample within a short analysis time and with suitable peak symmetry and acceptable efficiency. To optimize chromatographic separation, we tested different types of stationary phases on C8 and C18 columns with different lengths, and the best separation was found to be on two C18 columns: 250 × 4.6 mm, 5 μm for HPLC; and 100 × 4.6 mm, 2.6 μm for UPLC. Although the column used for the UPLC method had a particle size of 2.6 μm, comparatively larger than others used for the same technique (≤2 μm), this core shell column minimized mass transfer time and facilitated technique application a shorter column and applying 600 bar of pressure.
On the other hand, to optimize the mobile phase, in our preliminary trials we used different compositions and different ratios of water, methanol, and acetonitrile for the mobile phase; however, these did not provide good peak shape, and the elution of some of the components took much longer than 30 min. We found that an acetonitrile-methanol-phosphate buffer (pH 2.8; 10 + 15 + 75, v/v/v) was suitable for the separation of B1, B6, and B12, but poor separation of BEN and DIC. Finally, we used acetonitrile and 0.025 M phosphate buffer (pH 3.5) in different ratios, which provided good separation with symmetrical peaks. For HPLC, a gradient elution with an acetonitrile-phosphate buffer (pH 3.5) was started as 12 + 88 (v/v) to achieve 60 + 40 (v/v), which was maintained for 20 min, and then was applied to decrease the time of elution. For UPLC, elution began with 100% phosphate buffer (pH 3.5) for up to 1.8 min, then a gradual increase in acetonitrile to achieve 100% at 10 min.
By applying the previously mentioned gradient mobile phase, programming baseline separation was achieved for all five compounds with best peak shape and minimal background noise.
The flow rate was varied between 0.8 and 1.5 mL/min for HPLC and 0.5 and 1.0 mL/min for UPLC. The best separation flow rate was obtained at 1.5 and 1.0 mL/min for HPLC and UPLC, respectively. In addition, the column temperature was varied between 25 and 60°C. A column temperature of 25°C was chosen for HPLC and 40°C for UPLC, which decreased back-pressure and offered superior resolution, with detection at 254 nm, as verified by accuracy and precision. The run time was reduced from 20 min in HPLC to 8 min for UPLC (Figures 2 and 3) . Although B12 could be also determined at 550 nm, the linearity range obtained was the same as at 01513-01521.indd 1516 12/10/16 3:32 AM 254 nm, which was chosen for its detection to allow single runs for the five compounds. The United States Pharmacopeia (USP; 26) suggests that system suitability tests could be performed prior quantitative analysis, these parameters include; tailing factor; the number of theoretical plates; retention time and its RSD, %; and symmetry. Typically, at least two of these criteria are required to demonstrate system suitability for proposed methods (Table 1) . We evaluated system suitability for our proposed methods and obtained results that were in good agreement with USP requirements.
Although the UPLC chromatogram representing the five compounds showed a small peak for B6, its peak area had very good correlation with corresponding concentrations in the 5.0-150.0 μg/mL range. Figure 4 shows B6 separation as having the same concentration as in Figure 3 , showing optimum peak parameters that comply with the system suitability parameters presented in Table 1 .
Method Validation
Linearity, which was established by least-squares linear regression analysis of the calibration curve, was evaluated by analyzing a series of different concentrations. For both methods, the calibration curve was linear in the range of 5.0 to 150.0 μg/ mL with correlation coefficients >0.999. Tables 2 and 3 present performance data and statistical parameters, including slope, intercept, SE of the slope and intercept, correlation coefficients, and LOD and LOQ values with precision results (RSD, %).
Within-and between-day variability precision data are summarized in Tables 2 and 3 . Precision studies were determined with different concentrations and confirmed by RSD, % values. Based on these results, there was no significant difference for the assay, whether within or between days. Repeatability was investigated by injecting three replicate assays of three different concentrations for each of the five standards on the same day, whereas intermediate precision was assessed by injecting standard solutions over the course of three consecutive days by different analysts on different columns for both methods. The accelerated stability study was performed on the five compounds in their pure forms to provide an indication of the selectivity of the applied method. Accelerated degradation was attempted using an acid (0.1N HCl), a base (0.1 M NaOH), and hydrogen peroxide (30%). The chromatograms of the five compounds, after being subjected to different degradation conditions, were checked for purity and no degradation was observed under the conditions used, which showed the specificity of the developed methods.
Analysis of Pharmaceutical Dosage Forms
The optimized methods were applied for the determination of Arthineur capsules and Milga tablets. Figures 5 and 6 show the chromatograms obtained upon analyzing the pharmaceutical products by both methods. The accuracy of the proposed methods and any possible excipient interference with the analysis from pharmaceutical dosage forms were evaluated by comparing the results with those obtained from the manufacturers' methods. The mean percentages of the five compounds from the proposed methods are shown in Table 4 . Both HPLC and UPLC showed similar accuracy and precision. For the purpose of comparison, the proposed methods were compared with the manufacturers' analytical methods for both capsules and tablets. Student's t-and F-tests (Table 4) revealed no statistically significant difference between the two developed methods from the manufacturers' methods in accuracy and precision.
Conclusions
We developed new HPLC and UPLC methods for the separation and quantification of five components in tablets and capsules. The remarkable advantages of UPLC compared with HPLC were found to be faster method, a 3-fold reduction in elution time, and less consumption of solvents. Also, UPLC was more advantageous than HPLC when calculating high theoretical plate values, which translates to higher efficiency. In addition, the stability study we conducted proved that the HPLC method, and consequently the UPLC method, could be used as a stability-indicating method.
Hence, we conclude that our described quantitative methods are simple, highly sensitive, accurate, fast-response, and lowcost for the determination of the five compounds we studied in tablet and capsule form. Reductions in cost, time, and solvent consumption are important environmental and QC considerations in the research and development of all analytical methods. These techniques can be readily adapted for routine analysis in analytical laboratories. b The mean is the average of three determinations.
c Precision was calculated using nine determinations in the intraday for repeatability and interday for intermediate precision. b The number in parentheses is the theoretical value for F-and t-tests at P = 0.05. 
